Risk of COVID-19 and other infectious diseases
First written in FY2021. 2 of 3 entries say "Dropped", first in FY2023. Latest entry: FY2024-Q2.
The whole theme swung hardest in 2020: 102 of 175 companies on the "Worse" side.
- FY2024-Q2DroppedAnnual report
「During the cumulative second-quarter period, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」
There is no renewed disclosure of COVID-19 as a standalone principal risk, and the status from the previous fiscal year has been maintained. - FY2023DroppedAnnual report
「Following the reclassification of COVID-19 to Category 5, economic activity began to resume, with improvements in consumption, employment and the income environment driven by the recovery of domestic mobility and the expansion of inbound tourism, among other factors.」
The risk from COVID-19 has been removed from the filing's list of principal risks as a standalone risk and is instead described as a factor in the resumption of economic activity. - FY2021First statedAnnual report
「If the spread of COVID-19 were to result in requests under a government-declared state of emergency for stores to suspend operations or shorten business hours, or for people to refrain from going out, this could affect the company's operating results.」
The company also describes the impact on product supply and operations if infections occur at stores, among producers, at logistics centers or shopping centers, or at other locations.